Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

DELTA

Financiado

Cerrado

AI Enabled Managemement of Patients at Risk of Diabetic Foot Ulcer

Diabetic foot ulcers (DFU) lead to approximately 150,000 amputations and €23 billion in costs in Europe each year. Of the 60 million diabetics in Europe , 1.5 million currently have a diabetic foot ulcer and 15 million will develo... ver más

30/11/2022

BLUEDROP MEDICAL

4M€

Presupuesto del proyecto: 4M€

Líder del proyecto

BLUEDROP MEDICAL LIMITED No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Ver 2 Participantes

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2022-11-30

EIC-SMEInst-2018-2020: SME instrument

I+D

Cerrada hace 7 años

0% 70% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

2 Participantes

BLUEDROP MEDICAL

2.50M€ | Lider

ORMAZABAL PROTECTION AUTOMAT...

491.42K€ | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

Doctomatic Development of advanced AI algorithms for remote patient mon... 75K€ Cerrado

PODIUM PODIUM A home device and cloud based software and algorit... 71K€ Cerrado

TECNOLOGÍA DE INTELIGENCIA ARTIFICIAL PARA LA... TECNOLOGÍA DE INTELIGENCIA ARTIFICIAL PARA LA MONITORIZACIÓN... 382K€ Cerrado

CPP2021-008635 Nuevas herramientas digitales de diagnóstico remoto, no inva... 174K€ Cerrado

SISTEMA DE SOPORTE AL DIAGNÓSTICO TRATAMIENT... SISTEMA DE SOPORTE AL DIAGNÓSTICO TRATAMIENTO Y CURA DE LAS... 474K€ Cerrado

SKINDETECTOR Application of the innovative data fusion based non invasive... 1M€ Cerrado

Duración del proyecto: 38 meses Fecha Inicio: 2019-09-04
Fecha Fin: 2022-11-30

Líder del proyecto

BLUEDROP MEDICAL LIMITED No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 4M€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Diabetic foot ulcers (DFU) lead to approximately 150,000 amputations and €23 billion in costs in Europe each year. Of the 60 million diabetics in Europe , 1.5 million currently have a diabetic foot ulcer and 15 million will develop on at some point in their life . Each ulcer takes 3-6 months to heal and costs upwards of €14,000 to treat, however, if hospitalisation or amputation is required these costs can be as high as €100,000 . Diabetic foot ulcers pose a significant burden on healthcare systems around the world. The NHS in England spends almost 1% of its entire annual budget (£1.13 billion) on the diabetic foot. Almost all of these ulcers and amputations are preventable through early identification and proper care. Bluedrop Medical are developing a remote monitoring system that uses computer vision and machine learning to predict and prevent diabetic foot ulcers (DFUs). The home-based device, taking the form of a bathroom scales, performs a daily scan of the patient’s feet. In 10 seconds, thermal and photographic data is collected and sent to the cloud. Advanced algorithms monitor daily foot scans to detect DFUs before they develop, providing actionable alerts to both patient and healthcare provider. The technique of temperature monitoring has been proven to prevent 70% of DFUs and Bluedrop Medical are building this technique into an easy and quick to use device enabled by advanced sensor technology, computer vision algorithms and machine learning. By preventing ulcers, the technology can prevent hundreds of thousands of amputations, improving lives and saving healthcare systems millions of euro each year. Bluedrop Medical is targeting the highest risk patients who currently have a 30-40% annual incidence of ulceration by preventing ulcers in this group a potential average saving of €3,000 per patient can be achieve

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores